Experts In Pharmaceutical Development and Manufacturing
Trusted, End-To-End
Pharmaceutical innovators, generics, and OTC owners rely on Halo Pharma to bring their small molecule therapeutics to market expeditiously, across a broad range of dosage forms and complexities, without compromising safety and quality.
End-to-end capabilities in our two North American state-of-the-art facilities create a continuum:
- Small-scale, design of experiment non-GMP batch manufacturing, clinical trial and registration batches; formulation, analytical method development, validation and stability services; and tech transfers and scale up
- Manufacturing complex oral solid dose, semi-solids, liquids, and suppositories; integrated packaging; order fulfillment, distribution, and demand management
Customers trust Halo Pharma with nearly 120 active product development projects and more than 90 active ANDA/NDAs.
Noramco Group
Halo is proudly part of the Noramco Group, joining Noramco and Purisys to provide customers with a complete North American-based supply chain solution covering clinical and commercial APIs through to clinical and commercial drug products.
Learn how to leverage a complete manufacturing option with the Noramco Group.
What Can We Make For You?
- Solids – from tablets and mini-tabs to granules, powders, and capsules.
- Liquids – including suspensions, syrups, and homogenization drops.
- Semi-solids – ointments, creams, gels, and lotions.
- Suppositories – in PVC hard shells or AL/AL shells.
- Steriles – COMING IN 2026
But that’s not all. We are experts at specialty dosage forms. Modified release formats. Stickpacks. Mini-tablets. ODTs. Controlled substances. And fixed dose combinations.
North American Facilities, Global Regulatory Reach
We find solutions to your development and manufacturing challenges in our Whippany, NJ, USA and Mirabel, QC, Canada facilities, providing proximity and access to leading biopharma hubs.
With outstanding regulatory track records and reciprocal approvals from FDA, DEA, Health Canada, European Medicines Agency, ANVISA, and MHRA, we support sales and production to key international markets.
Here for Innovators, Generics, OTCs
More than 85 unique customers, including a growing number of innovators and “Top 10” pharmaceutical and generics companies, call Halo their CDMO. We’re here to help customers of all sizes achieve their go-to-market goals.
Lean on the Lifecycle Experts
Understanding what it takes to develop, scale, and manufacture your drug product is at Halo Pharma’s core. Our team brings years of experience and passion to each project, collaborating with customers to deliver medicines to patients in need.
Whether you have a molecule in need of development or a drug product in need of commercial manufacture, Halo Pharma is here to help.
What Can We Make For You?
- Solids – from tablets and mini-tabs to granules, powders, and capsules.
- Liquids – including suspensions, syrups, and homogenization drops.
- Semi-solids – ointments, creams, gels, and lotions.
- Suppositories – in PVC hard shells or AL/AL shells.
- Steriles – COMING IN 2026
But that’s not all. We are experts at specialty dosage forms. Modified release formats. Stickpacks. Mini-tablets. ODTs. Controlled substances. And fixed dose combinations.
North American Facilities, Global Regulatory Reach
We find solutions to your development and manufacturing challenges in our Whippany, NJ, USA and Mirabel, QC, Canada facilities, providing proximity and access to leading biopharma hubs.
With outstanding regulatory track records and reciprocal approvals from FDA, DEA, Health Canada, European Medicines Agency, ANVISA, and MHRA, we support sales and production to key international markets.
Here for Innovators, Generics, OTCs
More than 85 unique customers, including a growing number of innovators and “Top 10” pharmaceutical and generics companies, call Halo their CDMO. We’re here to help customers of all sizes achieve their go-to-market goals.
Lean on the Lifecycle Experts
Understanding what it takes to develop, scale, and manufacture your drug product is at Halo Pharma’s core. Our team brings years of experience and passion to each project, collaborating with customers to deliver medicines to patients in need.
Whether you have a molecule in need of development or a drug product in need of commercial manufacture, Halo Pharma is here to help.
What Can We Make For You?
- Solids – from tablets and mini-tabs to granules, powders, and capsules.
- Liquids – including suspensions, syrups, and homogenization drops.
- Semi-solids – ointments, creams, gels, and lotions.
- Suppositories – in PVC hard shells or AL/AL shells.
- Steriles – COMING IN 2026
But that’s not all. We are experts at specialty dosage forms. Modified release formats. Stickpacks. Mini-tablets. ODTs. Controlled substances. And fixed dose combinations.
North American Facilities, Global Regulatory Reach
We find solutions to your development and manufacturing challenges in our Whippany, NJ, USA and Mirabel, QC, Canada facilities, providing proximity and access to leading biopharma hubs.
With outstanding regulatory track records and reciprocal approvals from FDA, DEA, Health Canada, European Medicines Agency, ANVISA, and MHRA, we support sales and production to key international markets.
Here for Innovators, Generics, OTCs
More than 85 unique customers, including a growing number of innovators and “Top 10” pharmaceutical and generics companies, call Halo their CDMO. We’re here to help customers of all sizes achieve their go-to-market goals.
Lean on the Lifecycle Experts
Understanding what it takes to develop, scale, and manufacture your drug product is at Halo Pharma’s core. Our team brings years of experience and passion to each project, collaborating with customers to deliver medicines to patients in need.
Whether you have a molecule in need of development or a drug product in need of commercial manufacture, Halo Pharma is here to help.